Cell-mediated immunity in human acute myeloblastic leukemia
✍ Scribed by C. Pauli; F. Vànky; R. Hast; C. Lindemalm; A. M. Udén; P. Reizenstein
- Publisher
- Springer-Verlag
- Year
- 1978
- Tongue
- English
- Weight
- 757 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
✦ Synopsis
Lymphocyte stimulation tests with autologous myeloblasts were performed in 31 patients with nonlymphatic acute leukemia. Twenty-five patients were receiving chemotherapy combined with immunotherapy; six received chemotherapy only. Thirteen nonleukemic patients with various disorders and six healthy control patients were also studied.
It was found that 4/15 patients in 9/38 tests had autologous lymphocytes stimulated by autologous circulating myeloblasts. Bone marrow cells also effected stimulation, significantly more often if the marrow was taken in relapse than when it was taken in remission.
However, so-called immunotherapy with allogeneic leukemic myeloblasts and BCG couM not be shown to increase these frequeneies. Nor did it significantly increase the degree of stimulation measured as DNA synthesis in lymphocytes.
📜 SIMILAR VOLUMES
## Abstract Children with acute lymphocytic leukemia (ALL) in remission and undergoing either chemotherapy or immunotherapy were tested for general cell‐mediated immunocompetence and cell‐mediated reactivity to tumor‐associated antigens (TAA) using the following parameters: skin tests with recall a
## Abstract Blast cells from patients with Acute Myeloblastic Leukemia (AML) were separated according to cell size using velocity sedimentation under unit gravity. Fractions obtained in this way were plated in methyl cellulose with a growth stimulator present in media conditioned by leukocytes in t